Grading of dysplasia in Barrett's oesophagus: substantial interobserver variation between general and gastrointestinal pathologists

Aims:  To determine interobserver variation in grading of dysplasia in Barrett's oesophagus (BO) between non‐expert general pathologists and expert gastrointestinal pathologists on the one hand and between expert pathologists on the other hand.

[1]  R. Haggitt,et al.  Barrett's esophagus, dysplasia, and adenocarcinoma. , 1994, Human pathology.

[2]  J. Goldblum,et al.  p53 expression in low grade dysplasia in Barrett's esophagus: correlation with interobserver agreement and disease progression , 2002, American Journal of Gastroenterology.

[3]  Paul Fockens,et al.  Endoscopic video autofluorescence imaging may improve the detection of early neoplasia in patients with Barrett's esophagus. , 2005, Gastrointestinal endoscopy.

[4]  M. Feith,et al.  Surgery for early stage esophageal adenocarcinoma , 2005, Journal of surgical oncology.

[5]  L. R. Macfarlane,et al.  Department of pathology , 1961, Journal of the Royal Army Medical Corps.

[6]  Prateek Sharma,et al.  p53 protein overexpression in low grade dysplasia (LGD) in barrett's esophagus: Immunohistochemical marker predictive of progression , 2001, American Journal of Gastroenterology.

[7]  Brigitte Mayinger,et al.  Evaluation of sensitivity and inter- and intra-observer variability in the detection of intestinal metaplasia and dysplasia in Barrett's esophagus with enhanced magnification endoscopy , 2006, Scandinavian journal of gastroenterology.

[8]  P. Blount,et al.  Flow-cytometric and histological progression to malignancy in Barrett's esophagus: prospective endoscopic surveillance of a cohort. , 1992, Gastroenterology.

[9]  R. R. Smith,et al.  The relationship between columnar epithelial dysplasia and invasive adenocarcinoma arising in Barrett's esophagus. , 1987, American journal of clinical pathology.

[10]  J K Greenson,et al.  Reproducibility of the diagnosis of dysplasia in Barrett esophagus: a reaffirmation. , 2001, Human pathology.

[11]  Kenneth K Wang,et al.  Updated Guidelines 2008 for the Diagnosis, Surveillance and Therapy of Barrett's Esophagus , 1998, The American Journal of Gastroenterology.

[12]  M. Younes,et al.  p53 Protein Accumulation Is a Specific Marker of Malignant Potential in Barrett's Metaplasia , 1997, Digestive Diseases and Sciences.

[13]  J. R. Landis,et al.  The measurement of observer agreement for categorical data. , 1977, Biometrics.

[14]  R. Playford.  New British Society of Gastroenterology (BSG) guidelines for the diagnosis and management of Barrett’s oesophagus , 2006, Gut.

[15]  R. Lebovitz,et al.  p53 protein accumulation in Barrett's metaplasia, dysplasia, and carcinoma: a follow-up study. , 1993, Gastroenterology.

[16]  R. Cestari,et al.  Long-term endoscopic surveillance of patients with Barrett's esophagus. incidence of dysplasia and adenocarcinoma: a prospective study , 2003, American Journal of Gastroenterology.

[17]  M J Bruno,et al.  Magnification endoscopy, high resolution endoscopy, and chromoscopy; towards a better optical diagnosis , 2003, Gut.

[18]  M F Dixon,et al.  The Vienna classification of gastrointestinal epithelial neoplasia , 2000, Gut.

[19]  P. Guillem.  How to Make a Barrett Esophagus: Pathophysiology of Columnar Metaplasia of the Esophagus , 2005, Digestive diseases and sciences.

[20]  J. V. van Lanschot,et al.  Clinical decision making in Barrett's oesophagus can be supported by computerized immunoquantitation and morphometry of features associated with proliferation and differentiation , 1998, The Journal of pathology.

[21]  E W Steyerberg,et al.  The burden of upper gastrointestinal endoscopy in patients with Barrett's esophagus. , 2006, Endoscopy.

[22]  E. Montgomery.  Is there a way for pathologists to decrease interobserver variability in the diagnosis of dysplasia? , 2005, Archives of pathology & laboratory medicine.

[23]  A. Bhattacharyya,et al.  Magnification chromoendoscopy for the detection of intestinal metaplasia and dysplasia in Barrett’s oesophagus , 2003, Gut.

[24]  W. Hop,et al.  Dysplasia and aneuploidy as markers of malignant degeneration in Barrett's oesophagus. The Rotterdam Oesophageal Tumour Study Group. , 1994, Gut.

[25]  G. Falk.  Barrett's Esophagus—Is It Bad for Your Health? , 2005, The American Journal of Gastroenterology.

[26]  Kenneth K Wang,et al.  Mechanisms of Disease: carcinogenesis in Barrett's esophagus , 2004, Nature Clinical Practice Gastroenterology &Hepatology.

[27]  H. Mashimo,et al.  ALIMENTARY TRACT: ESOPHAGUS Surveillance and Screening for Barrett Esophagus and Adenocarcinoma , 2005 .

[28]  G. Landberg,et al.  Ki67 and p53 immunohistochemistry reduces interobserver variation in assessment of Barrett's oesophagus , 2005, Histopathology.

[29]  M. Diebold,et al.  [Reproducibility of histological criteria of dysplasia in Barrett mucosa]. , 1994, Gastroenterologie clinique et biologique.

[30]  G Van Belle,et al.  Observer variation in the diagnosis of dysplasia in Barrett's esophagus. , 1988, Human pathology.

[31]  O. Cummings,et al.  Variable pathologic interpretation of columnar lined esophagus by general pathologists in community practice. , 1999, Gastrointestinal endoscopy.

[32]  E. Kuipers,et al.  Oesophageal cancer incidence and mortality in patients with long-segment Barrett's Oesophagus after a mean follow-up of 12.7 years , 2004, Scandinavian journal of gastroenterology.

[33]  Gary Longton,et al.  Predictors of progression to cancer in Barrett's esophagus: baseline histology and flow cytometry identify low- and high-risk patient subsets , 2000, American Journal of Gastroenterology.

[34]  G. Meijer,et al.  Routine morphometrical analysis can improve reproducibility of dysplasia grade in Barrett’s oesophagus surveillance biopsies , 2002, Journal of clinical pathology.

[35]  J. G. van den Tweel,et al.  Barrett's esophagus: development of dysplasia and adenocarcinoma. , 1989, Gastroenterology.

[36]  A. Sonnenberg,et al.  Hiatal hernia size, Barrett's length, and severity of acid reflux are all risk factors for esophageal adenocarcinoma , 2002, American Journal of Gastroenterology.

[37]  R. Sampliner,et al.  Updated guidelines for the diagnosis, surveillance, and therapy of Barrett's esophagus , 2002, American Journal of Gastroenterology.